-
1
-
-
0038823558
-
Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate
-
Amat S., Bougnoux P., Penault-llorca F., Fétissof F., Curé H., Kwiatkowski F., et al. Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. Br J Cancer. 88:2003;1339-1345.
-
(2003)
Br J Cancer
, vol.88
, pp. 1339-1345
-
-
Amat, S.1
Bougnoux, P.2
Penault-Llorca, F.3
Fétissof, F.4
Curé, H.5
Kwiatkowski, F.6
-
2
-
-
85008998707
-
The effect on primary tumor response of adding sequential taxotere to adriamycin and cyclophosphamide: Preliminary results from NSABP protocol B-27
-
(abs.)
-
Bear H. The effect on primary tumor response of adding sequential taxotere to adriamycin and cyclophosphamide: preliminary results from NSABP protocol B-27. Breast Cancer Res Treat. 69:2001;201. (abs.).
-
(2001)
Breast Cancer Res Treat
, vol.69
, pp. 201
-
-
Bear, H.1
-
3
-
-
0026507925
-
Neoadjuvant chemotherapy in 126 operable breast cancers
-
Belembaogo E., Feillel V., Chollet P., Cure H., Verrelle P., Kwiatkowsky F., et al. Neoadjuvant chemotherapy in 126 operable breast cancers. Eur J Cancer. 28A:1992;896-900.
-
(1992)
Eur J Cancer
, vol.28
, pp. 896-900
-
-
Belembaogo, E.1
Feillel, V.2
Chollet, P.3
Cure, H.4
Verrelle, P.5
Kwiatkowsky, F.6
-
4
-
-
0037077831
-
Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy
-
Bertheau P., Plassa F., Espié M., Turpin E., de Rocquancourt A., Marty M., et al. Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy. Lancet. 360:2002;852.
-
(2002)
Lancet
, vol.360
, pp. 852
-
-
Bertheau, P.1
Plassa, F.2
Espié, M.3
Turpin, E.4
De Rocquancourt, A.5
Marty, M.6
-
5
-
-
0031972858
-
Primary chemotherapy in operable breast cancer: Eight year experience at the Milan Cancer Institute
-
Bonadonna G., Valagussa P., Brambilla C., Ferrari L., Moliterni A., Terenziani M., et al. Primary chemotherapy in operable breast cancer: eight year experience at the Milan Cancer Institute. J Clin Oncol. 16:1998;1539-1545.
-
(1998)
J Clin Oncol
, vol.16
, pp. 1539-1545
-
-
Bonadonna, G.1
Valagussa, P.2
Brambilla, C.3
Ferrari, L.4
Moliterni, A.5
Terenziani, M.6
-
6
-
-
8244258025
-
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
-
Brain E., Garrino C., Misset J., Carbonero I., Itzhaki M., Cvitkovic E., et al. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. Br J Cancer. 75:1997;1360-1367.
-
(1997)
Br J Cancer
, vol.75
, pp. 1360-1367
-
-
Brain, E.1
Garrino, C.2
Misset, J.3
Carbonero, I.4
Itzhaki, M.5
Cvitkovic, E.6
-
7
-
-
0033428140
-
Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: An updated analysis of a randomized trial
-
Broet P., Scholl S., de la Rochefordière A., Fourquet A., Moreau T., De Rycke Y., et al. Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial. Breast Cancer Res Treat. 58:1999;151-156.
-
(1999)
Breast Cancer Res Treat
, vol.58
, pp. 151-156
-
-
Broet, P.1
Scholl, S.2
De La Rochefordière, A.3
Fourquet, A.4
Moreau, T.5
De Rycke, Y.6
-
8
-
-
0028068245
-
Conservative treatment feasibility with induction chemotherapy, Surgery, and Radiotherapy for patients with patients with breast carcinoma larger than 3 cm
-
Calais G., Berger C., Descamps P., Chapet S., Reynaud-Bougnoux A., Body G., et al. Conservative treatment feasibility with induction chemotherapy, Surgery, and Radiotherapy for patients with patients with breast carcinoma larger than 3 cm. Cancer. 74:1994;1283-1288.
-
(1994)
Cancer
, vol.74
, pp. 1283-1288
-
-
Calais, G.1
Berger, C.2
Descamps, P.3
Chapet, S.4
Reynaud-Bougnoux, A.5
Body, G.6
-
9
-
-
0032887665
-
Biological markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer
-
Chang J., Powles T., Alred D., Ashley S., Clark G., Makris A., et al. Biological markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol. 17:1999;3058-3063.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3058-3063
-
-
Chang, J.1
Powles, T.2
Alred, D.3
Ashley, S.4
Clark, G.5
Makris, A.6
-
10
-
-
0037687355
-
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postopertaive adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/Cancer and Leukemia group B trial 9741
-
Citron M., Berry D., Cirrincione C., Hudis C., Winer E., Gradishar W., et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postopertaive adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741/Cancer and Leukemia group B trial 9741. J Clin Oncol. 21:2003;1431-1439.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1431-1439
-
-
Citron, M.1
Berry, D.2
Cirrincione, C.3
Hudis, C.4
Winer, E.5
Gradishar, W.6
-
11
-
-
0032055261
-
Pre-operative chemotherapy and radiotherapy in breast cancer
-
Colleoni M., Nole F., Minchella I., Noberasco C., Luini A., Orecchia A., et al. Pre-operative chemotherapy and radiotherapy in breast cancer. Eur J Cancer. 34:1998;641-645.
-
(1998)
Eur J Cancer
, vol.34
, pp. 641-645
-
-
Colleoni, M.1
Nole, F.2
Minchella, I.3
Noberasco, C.4
Luini, A.5
Orecchia, A.6
-
12
-
-
0036838046
-
Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy
-
Cure H., Amat S., Penault-Llorca F., le Bouedec G., Ferriere J., Pouret-Reynier M., et al. Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy. Breast Cancer Res Treat. 76:2002;37-45.
-
(2002)
Breast Cancer Res Treat
, vol.76
, pp. 37-45
-
-
Cure, H.1
Amat, S.2
Penault-Llorca, F.3
Le Bouedec, G.4
Ferriere, J.5
Pouret-Reynier, M.6
-
13
-
-
0008703742
-
Effect of preoperative chemotherapy on axillary lymph node metastases in stage II breast cancer: A prospective randomized trial
-
Danforth D., Jacobson J., O'Shaugnessy J., Zujewski J., Riseberg D., Denicoff A., et al. Effect of preoperative chemotherapy on axillary lymph node metastases in stage II breast cancer: a prospective randomized trial. Proc Annu Meet Am Soc Clin Oncol. 14:1995;A213.
-
(1995)
Proc Annu Meet Am Soc Clin Oncol
, vol.14
, pp. 213
-
-
Danforth, D.1
Jacobson, J.2
O'Shaugnessy, J.3
Zujewski, J.4
Riseberg, D.5
Denicoff, A.6
-
14
-
-
0031982870
-
Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer
-
Ellis P., Smith I., Ashley S., Walsh G., Ebbs S., Baum M., et al. Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer. J Clin Oncol. 16:1998;107-114.
-
(1998)
J Clin Oncol
, vol.16
, pp. 107-114
-
-
Ellis, P.1
Smith, I.2
Ashley, S.3
Walsh, G.4
Ebbs, S.5
Baum, M.6
-
15
-
-
0031926839
-
Effects of primary chemotherapy on the outcome of women with operable breast cancer
-
Fisher B., Bryant J., Wolmark N., Mamounas E., Brown A., Fisher E., et al. Effects of primary chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 16:1998;2672-2685.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2672-2685
-
-
Fisher, B.1
Bryant, J.2
Wolmark, N.3
Mamounas, E.4
Brown, A.5
Fisher, E.6
-
16
-
-
0024553695
-
Effect of local or systemic treatment prior to tumor removal on the production and response to a serum growth-stimulating factor in mice
-
Fisher B., Saffer E., Rudock C., Coyle J., Gunduz N. Effect of local or systemic treatment prior to tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Res. 49:1989;2002-2004.
-
(1989)
Cancer Res
, vol.49
, pp. 2002-2004
-
-
Fisher, B.1
Saffer, E.2
Rudock, C.3
Coyle, J.4
Gunduz, N.5
-
17
-
-
0037103104
-
Pathobiology of preoperative chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel (NSABP) Protocol B-18
-
Fisher E., Wang J., Bryant J., Fisher B., Mamounas E., Wolmark N. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) Protocol B-18. Cancer. 95:2002;681-695.
-
(2002)
Cancer
, vol.95
, pp. 681-695
-
-
Fisher, E.1
Wang, J.2
Bryant, J.3
Fisher, B.4
Mamounas, E.5
Wolmark, N.6
-
18
-
-
0030657740
-
Original P53 status predicts for pathological response in locally advanced breast cancer patients preoperatively treated with continuous infusion 5-fluorouracil and radiation therapy
-
Formenti S., Dunnington G., Uzieli B., et al. Original P53 status predicts for pathological response in locally advanced breast cancer patients preoperatively treated with continuous infusion 5-fluorouracil and radiation therapy. Int J Radiat Oncol Biol Phys. 39:1997;1059-1068.
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.39
, pp. 1059-1068
-
-
Formenti, S.1
Dunnington, G.2
Uzieli, B.3
-
19
-
-
0036472185
-
Low HER2/Neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer
-
Formenti S., Spicer D., Skinner K., Cohen D., Groshen S., Bettini A., et al. Low HER2/Neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 52:2002;397-405.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 397-405
-
-
Formenti, S.1
Spicer, D.2
Skinner, K.3
Cohen, D.4
Groshen, S.5
Bettini, A.6
-
20
-
-
0037364373
-
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trial
-
Formenti S., Volm M., Skinner K., Spicer D., Cohen D., Perez E., et al. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial. J Clin Oncol. 21:2003;864-870.
-
(2003)
J Clin Oncol
, vol.21
, pp. 864-870
-
-
Formenti, S.1
Volm, M.2
Skinner, K.3
Spicer, D.4
Cohen, D.5
Perez, E.6
-
21
-
-
0032944172
-
Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and post-operative radiotherapy
-
Fortin A., Larochelle M., Laverdière J., Lavertu S., Tremblay D. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and post-operative radiotherapy. J Clin Oncol. 17:1999;101-109.
-
(1999)
J Clin Oncol
, vol.17
, pp. 101-109
-
-
Fortin, A.1
Larochelle, M.2
Laverdière, J.3
Lavertu, S.4
Tremblay, D.5
-
22
-
-
0011715451
-
First report of the European Cooperative Trial in operable breast cancer (ECTO): Effect of primary systemic therapy (PST) on local-regional disease
-
Gianni L., Baselga J., Eiermann W., Guillem V., Semiglazov V., Garcia-Conde J., et al. First report of the European Cooperative Trial in operable breast cancer (ECTO): effect of primary systemic therapy (PST) on local-regional disease. Proc ASCO. 21:2002;132.
-
(2002)
Proc ASCO
, vol.21
, pp. 132
-
-
Gianni, L.1
Baselga, J.2
Eiermann, W.3
Guillem, V.4
Semiglazov, V.5
Garcia-Conde, J.6
-
23
-
-
0025288575
-
Results of neo-adjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer
-
Jacquillat C., Weill M., Baillet F., Borel C., Auclerc G., de Maublanc M., et al. Results of neo-adjuvant chemotherapy and radiation therapy in the breast conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer. 66:1990;119-129.
-
(1990)
Cancer
, vol.66
, pp. 119-129
-
-
Jacquillat, C.1
Weill, M.2
Baillet, F.3
Borel, C.4
Auclerc, G.5
De Maublanc, M.6
-
24
-
-
0038013982
-
International Expert Panel on the Use of Primary (preoperative) systemic treatment of operable breast Cancer: Review and recommandations
-
Kaufmann M., von Minckwitz G., Smith R., Valero V., Gianni L., Eiermann W., et al. International Expert Panel on the Use of Primary (preoperative) systemic treatment of operable breast Cancer: review and recommandations. J Clin Oncol. 21:2003;2600-2608.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2600-2608
-
-
Kaufmann, M.1
Von Minckwitz, G.2
Smith, R.3
Valero, V.4
Gianni, L.5
Eiermann, W.6
-
25
-
-
0035705547
-
Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma
-
Kuerer H., Singletary S., Buzdar A., Ames F., Valero V., Buchholz T., et al. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg. 182:2001;601-608.
-
(2001)
Am J Surg
, vol.182
, pp. 601-608
-
-
Kuerer, H.1
Singletary, S.2
Buzdar, A.3
Ames, F.4
Valero, V.5
Buchholz, T.6
-
26
-
-
0031743702
-
A reduction in the requirement for mastectomy in a randomized trial of neoadjuvant chemo-endocrine therapy in primary breast cancer
-
Makris A., Powles T., Ashley S., Chang J., Hickish T., Tidy V., et al. A reduction in the requirement for mastectomy in a randomized trial of neoadjuvant chemo-endocrine therapy in primary breast cancer. Ann Oncol. 9:1998;1179-1184.
-
(1998)
Ann Oncol
, vol.9
, pp. 1179-1184
-
-
Makris, A.1
Powles, T.2
Ashley, S.3
Chang, J.4
Hickish, T.5
Tidy, V.6
-
28
-
-
0033058219
-
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up - Institut Bergonié Bordeaux Groupe Sein (IBBGS)
-
Mauriac L., MacGrogan G., Avril A., Durand M., Floquet A., Debled M., et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up - Institut Bergonié Bordeaux Groupe Sein (IBBGS). Ann Oncol. 10:1999;47-52.
-
(1999)
Ann Oncol
, vol.10
, pp. 47-52
-
-
Mauriac, L.1
MacGrogan, G.2
Avril, A.3
Durand, M.4
Floquet, A.5
Debled, M.6
-
29
-
-
0032885642
-
Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hossier Oncology Group
-
Miller K., Mc Caskill-Stevens W., Sisk J., Loesch D., Monaco F., Seshadri R., et al. Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: a randomized pilot trial of the Hossier Oncology Group. J Clin Oncol. 17:1999;3033-3037.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3033-3037
-
-
Miller, K.1
Mc Caskill-Stevens, W.2
Sisk, J.3
Loesch, D.4
Monaco, F.5
Seshadri, R.6
-
30
-
-
0023860354
-
Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: A cancer and leukemia group B study
-
Perloff M., Lesnick G., Korzun A., Chu F., Holland J., Thirlwell M., et al. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a cancer and leukemia group B study. J Clin Oncol. 6:1988;261-269.
-
(1988)
J Clin Oncol
, vol.6
, pp. 261-269
-
-
Perloff, M.1
Lesnick, G.2
Korzun, A.3
Chu, F.4
Holland, J.5
Thirlwell, M.6
-
31
-
-
0038740871
-
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. The role of clinical response
-
Pierga J., Mouret E., Laurence V., Savigioni A., Beuzeboc P., Dorval T., et al. Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. The role of clinical response. Eur J Cancer. 39:2003;1089-1096.
-
(2003)
Eur J Cancer
, vol.39
, pp. 1089-1096
-
-
Pierga, J.1
Mouret, E.2
Laurence, V.3
Savigioni, A.4
Beuzeboc, P.5
Dorval, T.6
-
32
-
-
0013108215
-
Preoperative versus postoperative adjuvant chemotherapy for stage I-II breast cancer. Long-term analysis of British Columbia randomized trial
-
Ragaz J., Baird R., Rebbeck P., Trevisan C., Goldie J., Coldman A. Preoperative versus postoperative adjuvant chemotherapy for stage I-II breast cancer. Long-term analysis of British Columbia randomized trial. Proc Annu Meet Am Soc Clin Oncol. 16:1997;A499.
-
(1997)
Proc Annu Meet Am Soc Clin Oncol
, vol.16
, pp. 499
-
-
Ragaz, J.1
Baird, R.2
Rebbeck, P.3
Trevisan, C.4
Goldie, J.5
Coldman, A.6
-
33
-
-
0036498789
-
Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes
-
Rouzier R., Extra J., Klijanienko J., Falcou M., Asselain B., Vincent-Salomon A., et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol. 20:2002;1304-1310.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1304-1310
-
-
Rouzier, R.1
Extra, J.2
Klijanienko, J.3
Falcou, M.4
Asselain, B.5
Vincent-Salomon, A.6
-
34
-
-
0027522333
-
Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer
-
Sauter E., Eisenberg B., Hoffman J., Ottery F., Boraas M., Goldstein L., et al. Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World J Surg. 17:1993;237-242.
-
(1993)
World J Surg
, vol.17
, pp. 237-242
-
-
Sauter, E.1
Eisenberg, B.2
Hoffman, J.3
Ottery, F.4
Boraas, M.5
Goldstein, L.6
-
35
-
-
0028357653
-
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours ceonsidered too large for breast conserving surgery: Premiminary results of a randomised trial S6
-
Scholl S., Fourquet A., Asselain B., Pierga J., Vilcoq J., Durand J., et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours ceonsidered too large for breast conserving surgery: premiminary results of a randomised trial S6. Eur J Cancer. 30A:1994;645-652.
-
(1994)
Eur J Cancer
, vol.30
, pp. 645-652
-
-
Scholl, S.1
Fourquet, A.2
Asselain, B.3
Pierga, J.4
Vilcoq, J.5
Durand, J.6
-
36
-
-
0028048459
-
Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIB-IIIA breast cancer
-
Semiglazov V., Topuzov E., Bavli J., Moiseyenko V., Ivanova O., Seleznev I., et al. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIB-IIIA breast cancer. Ann Oncol. 5:1994;591-595.
-
(1994)
Ann Oncol
, vol.5
, pp. 591-595
-
-
Semiglazov, V.1
Topuzov, E.2
Bavli, J.3
Moiseyenko, V.4
Ivanova, O.5
Seleznev, I.6
-
37
-
-
0037087562
-
Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel
-
Smith I., Heys S., Hutcheon A., Miler I., Payne S., Gilbert F., et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. 20:2002;1456-1466.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1456-1466
-
-
Smith, I.1
Heys, S.2
Hutcheon, A.3
Miler, I.4
Payne, S.5
Gilbert, F.6
-
38
-
-
0027506734
-
Primary medical (neo-adjuvant)chemotherapy for operable breast cancer
-
Smith I., Jones A., O'Brien M., McKinna J., Sacks N., Baum M. Primary medical (neo-adjuvant)chemotherapy for operable breast cancer. Eur J Cancer. 29A:1993;592-595.
-
(1993)
Eur J Cancer
, vol.29
, pp. 592-595
-
-
Smith, I.1
Jones, A.2
O'Brien, M.3
McKinna, J.4
Sacks, N.5
Baum, M.6
-
39
-
-
0035468731
-
Preoperative/neoadjuvant medical therapy for early breast cancer
-
Smith I., Lipton L. Preoperative/neoadjuvant medical therapy for early breast cancer. Lancet Oncol. 2:2001;561-570.
-
(2001)
Lancet Oncol
, vol.2
, pp. 561-570
-
-
Smith, I.1
Lipton, L.2
-
40
-
-
0030936891
-
Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer
-
Touboul E., Lefranc J., Blondon J., Buffat L., Deniaud E., Belkacémi Y., et al. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radioth. Oncol. 42:1997;219-229.
-
(1997)
Radioth. Oncol.
, vol.42
, pp. 219-229
-
-
Touboul, E.1
Lefranc, J.2
Blondon, J.3
Buffat, L.4
Deniaud, E.5
Belkacémi, Y.6
-
41
-
-
0035890633
-
Preoperative chemotherapy in primary operable breast cancer: Results from the European organization for research and treatment of cancer trial 10902
-
van der Hage J., van de Velde C., Julien J., Tubian-Hulin M., Vandervelden C., Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902. J Clin Oncol. 19:2001;4224-4237.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4224-4237
-
-
Van Der Hage, J.1
Van De Velde, C.2
Julien, J.3
Tubian-Hulin, M.4
Vandervelden, C.5
Duchateau, L.6
-
42
-
-
0034653910
-
The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after downstaging with induction chemotherapy
-
Vlastos G., Mirza N., Lenert J., Hunt K., Ames F., Feig B., et al. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after downstaging with induction chemotherapy. Cancer. 88:2000;1417-1424.
-
(2000)
Cancer
, vol.88
, pp. 1417-1424
-
-
Vlastos, G.1
Mirza, N.2
Lenert, J.3
Hunt, K.4
Ames, F.5
Feig, B.6
-
43
-
-
0033060223
-
Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel
-
von Minckwitz G., Dan Costa S., Eiermann W., Blohmer J., Tulusan A., Jackisch C., et al. Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol. 17:1999;1999-2005.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1999-2005
-
-
Von Minckwitz, G.1
Dan Costa, S.2
Eiermann, W.3
Blohmer, J.4
Tulusan, A.5
Jackisch, C.6
-
44
-
-
0034035650
-
Primary systemic therapy in operable breast cancer
-
Wolff A., Davidson N. Primary systemic therapy in operable breast cancer. J Clin Oncol. 18:2000;1558-1569.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1558-1569
-
-
Wolff, A.1
Davidson, N.2
-
45
-
-
0035751675
-
Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from national surgical adjuvant breast and bowel project B-18
-
Wolmark N., Wang J., Mamounas E., Bryant J., Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from national surgical adjuvant breast and bowel project B-18. J Natl Cancer Inst Monogr. 30:2001;96-102.
-
(2001)
J Natl Cancer Inst Monogr
, vol.30
, pp. 96-102
-
-
Wolmark, N.1
Wang, J.2
Mamounas, E.3
Bryant, J.4
Fisher, B.5
|